(Q46474086)

22 December 2017

title

Impact of different case definitions for acute otitis media on the efficacy estimates of a pneumococcal conjugate vaccine (English)

1 reference

22 December 2017

pneumococcal conjugate vaccine

main subject

1 reference

1 reference

Arto Palmu

1

1 reference

22 December 2017

Jukka Jokinen

series ordinal

2

1 reference

22 December 2017

Terhi Kilpi

series ordinal

3

1 reference

22 December 2017

Finnish Otitis Media Study Group

series ordinal

4

1 reference

22 December 2017

language of work or name

English

0 references

publication date

31 March 2008

1 reference

22 December 2017

published in

Vaccine

1 reference

22 December 2017

volume

26

1 reference

22 December 2017

issue

20

1 reference

22 December 2017

page(s)

2466-2470

1 reference

22 December 2017

Antibiotic prescribing for Canadian preschool children: evidence of overprescribing for viral respiratory infections

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.013

Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.013

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.013

Efficacy of a pneumococcal conjugate vaccine against acute otitis media

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.013

National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.013

Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.013

Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conju

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.013

Lessons from recent studies on the epidemiology of otitis media.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.013

Increasing prevalence of recurrent otitis media among children in the United States.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.013

Increase in paediatric acute otitis media diagnosed by primary care in two Finnish municipalities--1994-5 versus 1978-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.013

Trends in antimicrobial prescribing rates for children and adolescents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.013

Impact of the pneumococcal conjugate vaccine on otitis media

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.013

Trends in doctor consultations, antibiotic prescription, and specialist referrals for otitis media in children: 1995-2003.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.013

10.1016/J.VACCINE.2008.03.013

7 January 2021

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017